Biomarkers for Myocardial Infarction and Chronic Heart Failure
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Texas Policy RPLAB046 alerts
Get alerted when Policy RPLAB046 changes without checking for updates manually.
Monitor payer policy activity
This reimbursement policy establishes laboratory management criteria for cardiac biomarkers used in evaluating acute coronary syndrome, myocardial infarction, dyspnea, and chronic heart failure. Requirements may vary by product and are subject to plan documents, provider contracts, coding rules, and claim review.
The 2026 document update revised the policy references while leaving reimbursement information unchanged.
A November 7, 2025 update included a literature review and changes to the Reimbursement Information section.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.